Metrics in Balance N.V. (EPA:MLMIB)
France · Delayed Price · Currency is EUR 0.0330
0.00 (0.00%)
At close: Aug 11, 2026
Metrics in Balance Revenue
In the year 2024, Metrics in Balance had annual revenue of 30.10K EUR with 9,933.33% growth.
Revenue
30.10K
Revenue Growth
+9,933.33%
P/S Ratio
4.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
144.89K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.10K | 29.80K | 9,933.33% |
| Dec 31, 2023 | 300.00 | - | - |
| Dec 31, 2022 | 300.00 | -54.72K | -99.45% |
| Dec 31, 2021 | 55.02K | 13.73K | 33.25% |
| Dec 31, 2020 | 41.29K | 8.57K | 26.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Spineway | 12.96M |
| Bluelinea Société Anonyme | 11.12M |
| Safe Orthopaedics | 5.36M |
| IntegraGen | 5.02M |